Global Pharmatech Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Global Pharmatech Private Limited Pharmaceutical Export Portfolio Dataset — 2 Products, $1.0M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Global Pharmatech Private Limited — Pharmaceutical Exporter Profile (2026) | 2 Products, $1.0M Trade | TransData Nexus

Global Pharmatech Private Limited

Indian Pharmaceutical Exporter · Cardiovascular Specialist · $1.0M Total Trade · DGFT Verified

Global Pharmatech Private Limited is an Indian pharmaceutical exporter with a total trade value of $1.0M across 2 products in 2 therapeutic categories. Based on 20 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Diltiazem ($650.0K), Ephedrine ($350.0K), .

Global Pharmatech Private Limited — Export Portfolio & Destination Treemap

Global Pharmatech Private Limited pharmaceutical export portfolio — 2 products across 2 therapeutic categories. Source: Indian Customs (DGFT).

Who is Global Pharmatech Private Limited? — Company Overview & Market Position

Global Pharmatech Private Limited, established on February 5, 1993, is a privately held Indian pharmaceutical company headquartered in Bangalore, Karnataka. The company is registered under the Corporate Identification Number (CIN) U24231KA1993PTC013976. As of the latest available data, Global Pharmatech has an authorized capital of ₹155.3 million and a paid-up capital of ₹146.935 million. The company's principal business activity falls under the category of 'Community, personal & Social Services.'

The registered office is located at IBC Knowledge Park, Phase 2, D Block, 9th Floor, 4/1, Bannerghatta Road, Bangalore, Karnataka 560029, India. The company is unlisted and has been operational for over three decades, focusing on the export of finished pharmaceutical formulations.

What Does Global Pharmatech Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Diltiazem$650.0K 2Ephedrine

Product Portfolio — Top 2 by Export Value

Global Pharmatech Private Limited exports 2 pharmaceutical products across 2 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Diltiazem	Cardiovascular	$650.0K	13	3.6%	6
2	Ephedrine	Respiratory & OTC	$350.0K	7	1.6%	11

Global Pharmatech Private Limited exports 2 pharmaceutical products across 2 therapeutic categories with a total export value of $1.0M. The top category is Cardiovascular (65.0% of portfolio), followed by Respiratory & OTC (35.0%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Global Pharmatech Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Global Pharmatech operates a manufacturing facility in Hosur, Tamil Nadu, which specializes in the production of high-quality liquid sterile formulations. The facility is capable of manufacturing both aseptically filled and terminally sterilized products, including small volume glass vials, ampoules, and large volume glass bottles. This plant is equipped to handle end-to-end pharmaceutical development and manufacturing processes, ranging from formulation development to global regulatory management.

3Key Leadership

The leadership team of Global Pharmatech Private Limited includes:

Anna Thomas Chacko: Director
Bipin Ratilal Shah: Director
Thomas Thomas: Director
Arumugam Bhaskar Krishna: Director
Sylvain Duvernay: Director

These individuals have been associated with the company since their respective appointments, contributing to its strategic direction and operational success.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Global Pharmatech Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Global Pharmatech Private Limited has established a presence in several regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company's manufacturing facility in Hosur, Tamil Nadu, holds certifications such as US FDA, EU GMP, Health Canada, and PIC/S, indicating compliance with international regulatory standards. These certifications facilitate the company's market access and product acceptance in these regions.

2Emerging Markets

In addition to its presence in regulated markets, Global Pharmatech Private Limited has expanded its reach to emerging markets in Africa, Latin America, and Southeast Asia. The company's WHO prequalification enables it to supply pharmaceutical products to these regions, enhancing access to quality medicines. This strategic expansion aligns with the company's mission to improve global health outcomes through affordable and reliable pharmaceutical solutions.

3Geographic Strategy

Global Pharmatech's geographic strategy demonstrates a balanced approach, with a significant portion of its exports directed towards the cardiovascular therapeutic category (65.0%) and the respiratory & OTC category (35.0%). This diversification mitigates concentration risk and positions the company to leverage opportunities across different therapeutic areas. The strategic direction focuses on expanding market presence while maintaining a diversified product portfolio to cater to a broad spectrum of patient needs.

Global Pharmatech Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

The manufacturing facility of Global Pharmatech Private Limited in Hosur, Tamil Nadu, is registered with the US Food and Drug Administration (FDA). The facility has undergone FDA inspections, with the most recent Form 483 issued on August 2, 2019, indicating areas for improvement. The company has taken corrective actions to address the observations, demonstrating a commitment to compliance and quality standards.

2WHO & EU GMP

Global Pharmatech Private Limited's manufacturing facility holds certifications from the World Health Organization (WHO) and the European Union Good Manufacturing Practice (EU GMP). These certifications affirm the company's adherence to international quality standards, ensuring the safety and efficacy of its pharmaceutical products. Such certifications are crucial for market acceptance and regulatory approvals in various global markets.

3CDSCO & Indian Regulatory

In India, Global Pharmatech Private Limited operates under the guidelines set by the Central Drugs Standard Control Organisation (CDSCO). The company's manufacturing facility in Hosur, Tamil Nadu, holds the necessary manufacturing licenses and approvals from state drug controllers, ensuring compliance with national regulatory requirements. Additionally, the company has obtained export No Objection Certificates (NOCs), facilitating the export of its pharmaceutical products to international markets.

Global Pharmatech Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

In the cardiovascular therapeutic category, Global Pharmatech Private Limited's product, Diltiazem, holds a market share of 3.6%, ranking 6th in the market. In the respiratory & OTC category, the company's product, Ephedrine, holds a market share of 1.6%, ranking 11th. These positions indicate a competitive presence in these therapeutic areas, with opportunities for growth through strategic initiatives and market expansion.

2Key Differentiators

Global Pharmatech Private Limited's key differentiators include its extensive experience in manufacturing high-quality liquid sterile formulations and its commitment to compliance with international regulatory standards. The company's WHO prequalification and EU GMP certifications enhance its credibility and marketability in global markets. Additionally, the company's diversified product portfolio across cardiovascular and respiratory & OTC categories allows it to cater to a broad spectrum of patient needs.

3Strategic Position

Global Pharmatech Private Limited's current strategic direction focuses on expanding its presence in both regulated and emerging markets, leveraging its manufacturing capabilities and regulatory certifications. The company's future outlook includes enhancing its product portfolio, strengthening its market position, and exploring opportunities in generics, specialty pharmaceuticals, and contract development and manufacturing organizations (CDMO) services. This strategic approach aims to drive sustainable growth and deliver value to stakeholders.

Buyer Due Diligence Brief — Evaluating Global Pharmatech Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Global Pharmatech Private Limited has demonstrated a consistent track record in pharmaceutical manufacturing, with a total export value of $1.0 million USD across 20 shipments. The company's portfolio concentration is notable, with its top 5 products accounting for 100% of its exports. This indicates a focused approach to product offerings, which can be advantageous in maintaining quality and operational efficiency. The company's adherence to international quality standards and regulatory certifications further underscores its reliability as a supplier.

2Certifications to Verify

Importers should verify the following certifications when considering Global Pharmatech Private Limited as a supplier:

FDA Registration: Confirm the facility's registration status with the US FDA to ensure compliance with US regulations.
WHO-GMP Certification: Verify the facility's certification from the World Health Organization to ensure adherence to international quality standards.

Frequently Asked Questions — Global Pharmatech Private Limited

How many pharmaceutical products does Global Pharmatech Private Limited export from India?

Global Pharmatech Private Limited exports 2 pharmaceutical products across 2 therapeutic categories. The top exports are Diltiazem ($650.0K), Ephedrine ($350.0K). Total export value is $1.0M.

What is Global Pharmatech Private Limited's total pharmaceutical export value?

Global Pharmatech Private Limited's total pharmaceutical export value is $1.0M, based on 20 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Global Pharmatech Private Limited cover?

Global Pharmatech Private Limited exports across 2 therapeutic categories. The largest are Cardiovascular (65.0%, 1 products), Respiratory & OTC (35.0%, 1 products).

Get Full Global Pharmatech Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.